tiprankstipranks
Advertisement
Advertisement
Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial
PremiumCompany AnnouncementsNovo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial
5d ago
Novo Nordisk announces European Commission approval of Wegovy pill
Premium
The Fly
Novo Nordisk announces European Commission approval of Wegovy pill
5d ago
Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors
Premium
Company Announcements
Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors
6d ago
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.22%
PremiumThe FlyCboe data shows mixed options sentiment in Novo Nordisk with shares up 1.22%
10d ago
Novo Nordisk Halts Device Study for CagriSema: What It Means for NVO Investors
Premium
Company Announcements
Novo Nordisk Halts Device Study for CagriSema: What It Means for NVO Investors
11d ago
Novo Nordisk Withdraws CagriSema Device Study, Nudging Investor Focus Back to Core Obesity Assets
Premium
Company Announcements
Novo Nordisk Withdraws CagriSema Device Study, Nudging Investor Focus Back to Core Obesity Assets
11d ago
Novo Nordisk price target raised to DKK 300 from DKK 280 at HSBC
PremiumThe FlyNovo Nordisk price target raised to DKK 300 from DKK 280 at HSBC
14d ago
Novo Nordisk Updates DKK 15 Billion Share Buyback as Treasury Stake Reaches 0.9%
Premium
Company Announcements
Novo Nordisk Updates DKK 15 Billion Share Buyback as Treasury Stake Reaches 0.9%
14d ago
Microsoft Parachuting 6,000 AI Engineers into Global Clients as Part of New $2.5B AI Subsidiary
Premium
Market News
Microsoft Parachuting 6,000 AI Engineers into Global Clients as Part of New $2.5B AI Subsidiary
18d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100